Pierre‐Eric Juif
47  results:
Search for persons X
?
2

Phase I/Ib, open-label, multicenter, dose-escalation study ..:

Bauer, Todd M ; Santoro, Armando ; Lin, Chia-Chi...
Journal for ImmunoTherapy of Cancer.  11 (2023)  11 - p. e007353 , 2023
 
?
3

Lack of Effect of Cenerimod, a Selective S1P1 Receptor Modu..:

Juif, Pierre-Eric ; Mueller, Markus S. ; Charfi, Hakim.
International Journal of Molecular Sciences.  23 (2022)  23 - p. 14986 , 2022
 
?
5

PK/PD modeling of a clazosentan thorough QT study with hyst..:

Henrich, Andrea ; Juif, Pierre-Eric ; Dingemanse, Jasper.
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2021)  2 - p. 213-224 , 2021
 
?
6

Modelling pharmacokinetics and pharmacodynamics of the sele..:

Lott, Dominik ; Juif, Pierre‐Eric ; Dingemanse, Jasper.
British Journal of Clinical Pharmacology.  86 (2020)  4 - p. 791-800 , 2020
 
?
 
?
11

Cardiodynamic Interactions between Two S1P1 Receptor Modula..:

Juif, Pierre-Eric ; Ufer, Mike ; Dingemanse, Jasper
International Journal of Molecular Sciences.  20 (2019)  13 - p. 3232 , 2019
 
?
12

Accelerated Development of the Dual Orexin Receptor Antagon..:

Muehlan, Clemens ; Heuberger, Jules ; Juif, Pierre‐Eric...
Clinical Pharmacology & Therapeutics.  104 (2018)  5 - p. 1022-1029 , 2018
 
?
13

Clinical Pharmacology of the Reversible and Potent P2Y12 Re..:

Juif, Pierre‐Eric ; Boehler, Margaux ; Dobrow, Michael..
The Journal of Clinical Pharmacology.  59 (2018)  1 - p. 123-130 , 2018
 
?
14

A pharmacokinetic drug–drug interaction study between selex..:

Juif, Pierre-Eric ; Boehler, Margaux ; Donazzolo, Yves..
European Journal of Clinical Pharmacology.  73 (2017)  9 - p. 1121-1128 , 2017
 
?
15

Pharmacokinetics, Pharmacodynamics, Tolerability, and Food ..:

Juif, Pierre-Eric ; Baldoni, Daniela ; Reyes, Maribel...
International Journal of Molecular Sciences.  18 (2017)  12 - p. 2636 , 2017
 
1-15